[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

KR850004492A - 옥시캄의 엔올 에테르 유도체의 제조방법 - Google Patents

옥시캄의 엔올 에테르 유도체의 제조방법 Download PDF

Info

Publication number
KR850004492A
KR850004492A KR1019840008144A KR840008144A KR850004492A KR 850004492 A KR850004492 A KR 850004492A KR 1019840008144 A KR1019840008144 A KR 1019840008144A KR 840008144 A KR840008144 A KR 840008144A KR 850004492 A KR850004492 A KR 850004492A
Authority
KR
South Korea
Prior art keywords
compound
preparing
formula
methyl
oxycam
Prior art date
Application number
KR1019840008144A
Other languages
English (en)
Other versions
KR860002035B1 (ko
Inventor
마페트 안토니
Original Assignee
윌리암 데이비스 훈
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 윌리암 데이비스 훈, 화이자 인코포레이티드 filed Critical 윌리암 데이비스 훈
Publication of KR850004492A publication Critical patent/KR850004492A/ko
Application granted granted Critical
Publication of KR860002035B1 publication Critical patent/KR860002035B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

내용 없음

Description

옥시캄의 엔올 에테르 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 일반식(Ⅲ) 또는 (Ⅳ)의 화합물의 음이온성 염을 일반식(Ⅴ)의 화합물과 반응시킴을 특징으로 하여, 일반식(Ⅰ) 또는 (Ⅱ)의 화합물을 제조하는 방법.
    이며, n은 2,3 또는 4이고; R2는 수소, 메틸 또는 페닐이며; R4및 R5는 각각 독립적으로 수소 또는 메틸이고; R3는 각 경우에 OR6또는 OCOR6으로 임의 치환되는 (C1-C10)알킬, (C3-C7)시클로알킬, 페닐 또는 벤질이며; R6은 (C1-C3)알킬이고; X는 친핵성 치환가능그룹이다.
  2. 제1항에 있어서, R이인 일반식(I)의 화합물을 제조하는 방법.
  3. 제2항에 있어서, R1가인 화합물을 제조하는 방법.
  4. 제3항에 있어서, R2가 메틸이고, R3가 메틸인 화합물을 제조하는 방법.
  5. 제2항에 있어서, R1이인 화합물을 제조하는 방법.
  6. 제5항에 있어서, R2가 메틸이고, R3가 에틸인 화합물을 제조하는 방법.
  7. 제1항에 있어서, R이이고, R1이일반식(Ⅰ)의 화합물을 제조하는 방법.
  8. 제1항에 있어서, R이이고, R1이일반식(Ⅰ)의 화합물을 제조하는 방법.
  9. 제1항에 있어서, R이이고, R1이일반식(Ⅱ)의 화합물을 제조하는 방법.
  10. 제1항에 있어서, X가 할로겐인 화합물을 제조하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840008144A 1983-12-21 1984-12-20 옥시캄의 엔올 에테르 유도체의 제조방법 KR860002035B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US56390283A 1983-12-21 1983-12-21
US563,902 1983-12-21
US563902 1983-12-21
US606,113 1984-05-02
US606113 1984-05-02
US06/606,113 US4551452A (en) 1983-12-21 1984-05-02 Anti-inflammatory 2-methyl-2H-1,2-benzo-(or -thieno-)thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor

Publications (2)

Publication Number Publication Date
KR850004492A true KR850004492A (ko) 1985-07-15
KR860002035B1 KR860002035B1 (ko) 1986-11-17

Family

ID=27073413

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840008144A KR860002035B1 (ko) 1983-12-21 1984-12-20 옥시캄의 엔올 에테르 유도체의 제조방법

Country Status (26)

Country Link
US (1) US4551452A (ko)
EP (1) EP0147177B1 (ko)
KR (1) KR860002035B1 (ko)
AU (1) AU552940B2 (ko)
BG (1) BG47946A3 (ko)
CA (1) CA1255302A (ko)
DD (1) DD229125A5 (ko)
DE (1) DE3466776D1 (ko)
DK (1) DK166678B1 (ko)
EG (1) EG17049A (ko)
ES (1) ES8604215A1 (ko)
FI (1) FI79850C (ko)
GR (1) GR82512B (ko)
HK (1) HK58589A (ko)
HU (1) HU201063B (ko)
IE (1) IE57680B1 (ko)
IL (1) IL73873A (ko)
MX (2) MX174596B (ko)
NO (1) NO161317C (ko)
NZ (1) NZ210632A (ko)
PH (1) PH21447A (ko)
PL (1) PL145989B1 (ko)
PT (1) PT79700B (ko)
RO (1) RO90048A (ko)
SG (1) SG27001G (ko)
YU (1) YU43677B (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778795A (en) * 1983-11-25 1988-10-18 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4906635A (en) * 1983-11-25 1990-03-06 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4616012A (en) * 1983-11-25 1986-10-07 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US5017567A (en) * 1983-11-25 1991-05-21 Schering Corporation Carboxyalkyl dipeptides as antiglaucoma agents
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
US4771071A (en) * 1986-05-05 1988-09-13 Merck & Co., Inc. Antihypercholesterolemic compounds
WO1987006933A1 (en) * 1986-05-16 1987-11-19 Pfizer Inc. Benzothiazine dioxide derivatives
WO1989003682A1 (en) * 1987-10-26 1989-05-05 Pfizer Inc. Benzothiazine dioxide derivatives
IL87951A (en) * 1987-10-29 1992-03-29 Chem Pharm Forsch Gmbh Carbonic acid esters of 6-chloro-4-(1-hydroxyethoxy)-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide,their preparation and pharmaceutical compositions containing them
ZA945190B (en) * 1993-07-30 1995-02-24 Kotobuki Seiyaku Co Ltd Carboxymethylidenecycloheptimidazole derivatives method or manufacturing the same and therapeutic agents containing these compounds
IT1308633B1 (it) 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
CN100389114C (zh) * 2006-01-17 2008-05-21 南京新港医药有限公司 一种安吡昔康的精制方法
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
CN101522692A (zh) * 2006-10-11 2009-09-02 于崇曦 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
US9371284B2 (en) 2007-06-04 2016-06-21 Techfields Pharma Co., Ltd. Pro-drugs of NSAIAS with very high skin and membranes penetration rates and their new medicinal uses
CN107320732B (zh) 2008-12-04 2021-09-07 于崇曦 高穿透性组合物及其应用
WO2013093931A2 (en) 2011-09-19 2013-06-27 Sun Pharma Advanced Research Company Ltd. Novel prodrugs of phenolic drugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3892740A (en) * 1974-10-15 1975-07-01 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
US4309427A (en) * 1981-01-15 1982-01-05 Pfizer Inc. Benzothiazine dioxide derivatives
IT1168064B (it) * 1981-11-12 1987-05-20 Prodotti Antibiotici Spa Composto ad azione antinfiammatoria
IT8219486A0 (it) * 1982-02-05 1982-02-05 Chiesi Farma Spa Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.

Also Published As

Publication number Publication date
NO161317C (no) 1989-08-02
DE3466776D1 (en) 1987-11-19
PH21447A (en) 1987-10-28
HUT37426A (en) 1985-12-28
EP0147177A2 (en) 1985-07-03
PL145989B1 (en) 1988-12-31
IE57680B1 (en) 1993-02-24
DK166678B1 (da) 1993-06-28
NO161317B (no) 1989-04-24
HU201063B (en) 1990-09-28
EP0147177B1 (en) 1987-10-14
EP0147177A3 (en) 1985-08-14
AU3699784A (en) 1985-07-04
YU43677B (en) 1989-10-31
PT79700A (en) 1985-01-01
FI845074A0 (fi) 1984-12-20
MX174596B (es) 1994-05-30
NZ210632A (en) 1987-02-20
FI79850C (fi) 1990-03-12
HK58589A (en) 1989-07-28
IE843260L (en) 1985-06-21
FI845074L (fi) 1985-06-22
NO845145L (no) 1985-06-24
SG27001G (en) 1989-08-11
RO90048A (ro) 1986-09-30
BG47946A3 (en) 1990-10-15
IL73873A0 (en) 1985-03-31
DD229125A5 (de) 1985-10-30
YU216084A (en) 1986-10-31
ES8604215A1 (es) 1986-01-16
US4551452A (en) 1985-11-05
KR860002035B1 (ko) 1986-11-17
ES538907A0 (es) 1986-01-16
MX9203740A (es) 1992-09-01
CA1255302A (en) 1989-06-06
PL251040A1 (en) 1985-10-22
DK614984D0 (da) 1984-12-20
EG17049A (en) 1991-03-30
FI79850B (fi) 1989-11-30
AU552940B2 (en) 1986-06-26
GR82512B (en) 1985-04-22
DK614984A (da) 1985-07-17
IL73873A (en) 1988-02-29
PT79700B (en) 1986-12-30

Similar Documents

Publication Publication Date Title
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
KR860009023A (ko) 치환된 실릴기를 갖는 신규 에테르 화합물의 제조방법
KR860000243A (ko) 아민유도체의 제조방법
KR840003260A (ko) [(3-아미노-3-카르복시)-프로필-1]포스핀산 유도체의 제조법
KR920016420A (ko) 치환된 테트라하이드로피리딘의 제조방법
KR860001097A (ko) 4-아미노-2-페닐퀴놀린의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR870003107A (ko) 키산틴 유도체의 제조방법
KR880011103A (ko) 5-아미노-4,6-디할로게노피리딘의 제조방법
KR850004470A (ko) 유기 화합물의 제조방법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR860004051A (ko) 치환된 페닐피페라진 유도체의 제조방법
KR830005122A (ko) 1-아릴옥시-3-알킬아미노-2-프로판올류의 제조방법
KR850002095A (ko) 4,7-디히드로피라졸로[3,4-b] 피리딘 유도체의 제조방법
KR860002486A (ko) 티아진포스폰산 유도체의 제조방법
KR860002451A (ko) 아미드 화합물의 제조방법
KR850006406A (ko) 4,7-디히드로피라졸[3,4-b] 피리딘 유도체의 제조방법
KR850004760A (ko) 이미다조 퀴놀린 유도체의 제조방법
KR850007247A (ko) 바이페닐릴설포닐 우레아의 제조방법
KR840003639A (ko) 이속사졸로피리미딘 유도체의 제조방법
KR870002118A (ko) 벤질아민 유도체 및 그 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR850004583A (ko) 페닐아세트아닐리드 유도체의 제조방법
KR870011144A (ko) 세팔로스포린 유도체의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20041011

Year of fee payment: 19

EXPY Expiration of term